Wednesday, July 18, 2012

July 2012: DMAA Found Not ‘Natural,’ Not Geranium

Our office has already filed one lawsuit claiming a horrible tragedy that befell a user of OxyElite Pro. This week there is new that DMAA is indeed a synthetic:

Chemical analysis of 1,3-dimethylamylamine (DMAA) from supplements found it indistinguishable from two known synthetic versions of the compound. Purportedly derived from geranium plants, DMAA did not show up in analyses of extracts from eight different types of geranium.
“It appears unlikely that the DMAA in supplements originates from natural sources, such as geranium oils, for three reasons,” Daniel W. Armstrong, PhD, of the University of Texas at Arlington, and co-authors wrote in conclusion in an article published online inDrug Testing and Analysis.
“The DMAA extracted from these supplement products had diastereomeric ratios that were indistinguishable from the synthetic DMAA standards. They are all racemic. No DMAA was detected at a level ≥10 parts per billion (ppb) in any of the eight geranium oil samples.”

Thursday, July 12, 2012

GE Healthcare recalls some ventilators

The FDA said GE had found that the ventilator's two vaporizers could deliver an anesthetic agent simultaneously, causing low blood pressure, irregular breathing and a drop in heart rate.
The recall of certain Aestiva/5 7900 ventilators, which started in April 2012, was classified a Class I recall - the most serious type of recall.
The Aestiva/5 7900 ventilator was approved by the U.S. Food and Drug Administration as an anesthesia machine in April 2000.

The Excedrin Recall Six Months Later

An interesting read in the NY Post about the recall of popular over the counter med Excedrin. 

The drug was recalled Jan. 9 over concerns that prescription painkillers had gotten mixed in with Excedrin at a Lincoln, Neb., plant.

Some bottles are now going for more than $100 on eBay.

Read more: